miR-651-3p Enhances the Sensitivity of Hepatocellular Carcinoma to Cisplatin via Targeting ATG3-Mediated Cell Autophagy

<div>ATG3 reversed the effect of miR-651-3p on the CDDP-resistance of R-HepG2 cells. (a) The viability of the resistant HepG2 after serial dosage DDP treatment observed by CCK-8. (b) The apoptosis level of resistant HepG2 with 5 <i>μ</i>M of CDDP measured by flow cytometry assay.</div>

Journal of Oncology

fig4

Figure 4

Figure 4: miR-651-3p Enhances the Sensitivity of Hepatocellular Carcinoma to Cisplatin via Targeting ATG3-Mediated Cell Autophagy 